CRMX2 Implied Volatility
CRMX2 options trade at a 30-day at-the-money implied volatility of 0.0%. This page breaks down CRMX2's implied volatility in plain English: where it sits versus its own history, how it compares with realized movement, and what the term structure and skew are saying.
Data as of Oct 8, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Implied Volatility & Expected Move
CRMX2 30-day at-the-money implied volatility, past year.
| ATM IV — front expiration | 0.0% |
| ATM IV — 2 month | 0.0% |
| ATM IV — 3 month | 105.2% |
| IV percentile (1 year) | 0% |
| Expected move (front expiration) | ±0.0% |
| Term slope (front − 3M) | -105.2 pts |
The term structure is in contango — front-month IV sits below 3-month IV, the typical shape in calm markets.
Explore the payoff profile of option on CRMX2 for free
Build multi-leg CRMX2 strategies, visualize payoffs, and scan the full US options universe with OptiView.
CRMX2 Options FAQ
What is the implied volatility of CRMX2 options?
CRMX2 options trade at a 30-day at-the-money implied volatility of 0.0% as of Oct 8, 2026.
What move do CRMX2 options imply before the next expiration?
Front-expiration CRMX2 options imply a one-standard-deviation move of ±0.0% as of Oct 8, 2026, derived from at-the-money option prices.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.